This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Jan. 28, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its fourth quarter and year ended
December 31, 2012 after the market closes on
Tuesday, February 5, 2013.
Alan D. Gold, Chairman and Chief Executive Officer,
Kent Griffin, President,
Matt McDevitt, Executive Vice President, and
Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at
11:00 a.m. Pacific Time on
Wednesday, February 6, 2013 to discuss the company's financial results and operations for the year.
The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at
www.biomedrealty.com and at
www.earnings.com, which will include an online slide presentation to accompany the call, or live by calling (877) 261-8990 (domestic) or (847) 619-6441 (international) with call ID number 34178179. The complete webcast will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from
1:30 p.m. Pacific Time on
Wednesday, February 6, 2013 until
midnight Pacific Time on
Monday, February 11, 2013 by calling (888) 843-7419 (domestic) or (630) 652-3042 (international) and using access code 34178179#.
About BioMed Realty Trust BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 13.1 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of
Seattle, which have well-established reputations as centers for scientific research. Additional information is available at
SOURCE BioMed Realty Trust, Inc.